91 related articles for article (PubMed ID: 17573813)
1. The central nervous system in mucosal vaccination of rhesus macaques with simian immunodeficiency virus Deltanef.
Georgsson G; Stahl-Hennig C; Tenner-Racz K; Uberla K; Stoiber H; Uguccioni M; Dierich M; Ignatius R; Steinman RM; Racz P
Neuropathol Appl Neurobiol; 2007 Dec; 33(6):644-57. PubMed ID: 17573813
[TBL] [Abstract][Full Text] [Related]
2. Analysis of humoral immune responses in rhesus macaques vaccinated with attenuated SIVmac239Deltanef and challenged with pathogenic SIVmac251.
Freissmuth D; Hiltgartner A; Stahl-Hennig C; Fuchs D; Tenner-Racz K; Racz P; Uberla K; Strasak A; Dierich MP; Stoiber H; Falkensammer B
J Med Primatol; 2010 Apr; 39(2):97-111. PubMed ID: 20015159
[TBL] [Abstract][Full Text] [Related]
3. Protection from pathogenic SIVmac challenge following short-term infection with a nef-deficient attenuated virus.
Norley S; Beer B; Binninger-Schinzel D; Cosma C; Kurth R
Virology; 1996 May; 219(1):195-205. PubMed ID: 8623530
[TBL] [Abstract][Full Text] [Related]
4. Pathogenic and nef-interrupted simian-human immunodeficiency viruses traffic to the macaque CNS and cause astrocytosis early after inoculation.
Singh DK; McCormick C; Pacyniak E; Griffin D; Pinson DM; Sun F; Berman NE; Stephens EB
Virology; 2002 Apr; 296(1):39-51. PubMed ID: 12036316
[TBL] [Abstract][Full Text] [Related]
5. Persistence of pathogenic challenge virus in macaques protected by simian immunodeficiency virus SIVmacDeltanef.
Khatissian E; Monceaux V; Cumont MC; Kieny MP; Aubertin AM; Hurtrel B
J Virol; 2001 Feb; 75(3):1507-15. PubMed ID: 11152522
[TBL] [Abstract][Full Text] [Related]
6. Highly attenuated rabies virus-based vaccine vectors expressing simian-human immunodeficiency virus89.6P Env and simian immunodeficiency virusmac239 Gag are safe in rhesus macaques and protect from an AIDS-like disease.
McKenna PM; Koser ML; Carlson KR; Montefiori DC; Letvin NL; Papaneri AB; Pomerantz RJ; Dietzschold B; Silvera P; McGettigan JP; Schnell MJ
J Infect Dis; 2007 Apr; 195(7):980-8. PubMed ID: 17330788
[TBL] [Abstract][Full Text] [Related]
7. Improved protection against simian immunodeficiency virus mucosal challenge in macaques primed with a DNA vaccine and boosted with the recombinant modified vaccinia virus Ankara and recombinant Semliki Forest virus.
Martinon F; Brochard P; Ripaux M; Delache B; Aurégan G; Vaslin B; Le Grand R
Vaccine; 2008 Jan; 26(4):532-45. PubMed ID: 18093703
[TBL] [Abstract][Full Text] [Related]
8. Expression of proinflammatory cytokines and its relationship with virus infection in the brain of macaques inoculated with macrophage-tropic simian immunodeficiency virus.
Xing HQ; Moritoyo T; Mori K; Sugimoto C; Ono F; Izumo S
Neuropathology; 2009 Feb; 29(1):13-9. PubMed ID: 18507770
[TBL] [Abstract][Full Text] [Related]
9. Early protection against pathogenic virus infection at a mucosal challenge site after vaccination with attenuated simian immunodeficiency virus.
Tenner-Racz K; Stahl Hennig C; Uberla K; Stoiber H; Ignatius R; Heeney J; Steinman RM; Racz P
Proc Natl Acad Sci U S A; 2004 Mar; 101(9):3017-22. PubMed ID: 14970317
[TBL] [Abstract][Full Text] [Related]
10. Augmentation of antigen-specific cytokine responses in the early phase of vaccination with a live-attenuated simian/human immunodeficiency chimeric virus expressing IFN-gamma.
Iida T; Kuwata T; Ui M; Suzuki H; Miura T; Ibuki K; Takahashi H; Yamamoto T; Imanishi J; Hayami M; Kita M
Arch Virol; 2004 Apr; 149(4):743-57. PubMed ID: 15045561
[TBL] [Abstract][Full Text] [Related]
11. Live attenuated, multiply deleted simian immunodeficiency virus causes AIDS in infant and adult macaques.
Baba TW; Liska V; Khimani AH; Ray NB; Dailey PJ; Penninck D; Bronson R; Greene MF; McClure HM; Martin LN; Ruprecht RM
Nat Med; 1999 Feb; 5(2):194-203. PubMed ID: 9930868
[TBL] [Abstract][Full Text] [Related]
12. Vaccine-induced, simian immunodeficiency virus-specific CD8+ T cells reduce virus replication but do not protect from simian immunodeficiency virus disease progression.
Engram JC; Dunham RM; Makedonas G; Vanderford TH; Sumpter B; Klatt NR; Ratcliffe SJ; Garg S; Paiardini M; McQuoid M; Altman JD; Staprans SI; Betts MR; Garber DA; Feinberg MB; Silvestri G
J Immunol; 2009 Jul; 183(1):706-17. PubMed ID: 19542473
[TBL] [Abstract][Full Text] [Related]
13. SIV escape mutants in rhesus macaques vaccinated with NEF-derived lipopeptides and challenged with pathogenic SIVmac251.
Villefroy P; Letourneur F; Coutsinos Z; Mortara L; Beyer C; Gras-Masse H; Guillet JG; Bourgault-Villada I
Virol J; 2006 Aug; 3():65. PubMed ID: 16945152
[TBL] [Abstract][Full Text] [Related]
14. Prolonged survival of vaccinated macaques after oral SIVmac239 challenge regardless of viremia control in the chronic phase.
Suh YS; Park KS; Sauermann U; Kim KS; Ahn SS; Franz M; Schulte R; Wilfingseder D; Stoiber H; Uberla K; Hunsmann G; Stahl-Hennig C; Sung YC
Vaccine; 2008 Dec; 26(51):6690-8. PubMed ID: 18694796
[TBL] [Abstract][Full Text] [Related]
15. Early viral replication in the brain of SIV-infected rhesus monkeys.
Chakrabarti L; Hurtrel M; Maire MA; Vazeux R; Dormont D; Montagnier L; Hurtrel B
Am J Pathol; 1991 Dec; 139(6):1273-80. PubMed ID: 1750503
[TBL] [Abstract][Full Text] [Related]
16. A single vaccination with attenuated SIVmac 239 via the tonsillar route confers partial protection against challenge with SIVmac 251 at a distant mucosal site, the rectum.
Stahl-Hennig C; Eisenblatter M; Franz M; Stoiber H; Tenner-Racz K; Suh YS; Jasny E; Falkensammer B; Ugucchioni M; Georgsson G; Baroni C; Dierich MP; Lifson JD; Steinman RM; Uberla K; Racz P; Ignatius R
Front Biosci; 2007 Jan; 12():2107-23. PubMed ID: 17127448
[TBL] [Abstract][Full Text] [Related]
17. Early SIV encephalopathy.
Hurtrel B; Chakrabarti L; Hurtrel M; Maire MA; Dormont D; Montagnier L
J Med Primatol; 1991 Jun; 20(4):159-66. PubMed ID: 1942006
[TBL] [Abstract][Full Text] [Related]
18. Immune mechanisms associated with protection from vaginal SIV challenge in rhesus monkeys infected with virulence-attenuated SHIV 89.6.
Miller CJ; Abel K
J Med Primatol; 2005 Oct; 34(5-6):271-81. PubMed ID: 16128922
[TBL] [Abstract][Full Text] [Related]
19. Mucosal prior to systemic application of recombinant adenovirus boosting is more immunogenic than systemic application twice but confers similar protection against SIV-challenge in DNA vaccine-primed macaques.
Schulte R; Suh YS; Sauermann U; Ochieng W; Sopper S; Kim KS; Ahn SS; Park KS; Stolte-Leeb N; Hunsmann G; Sung YC; Stahl-Hennig C
Virology; 2009 Jan; 383(2):300-9. PubMed ID: 19027133
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal study to assess the safety and efficacy of a live-attenuated SHIV vaccine in long term immunized rhesus macaques.
Yankee TM; Sheffer D; Liu Z; Dhillon S; Jia F; Chebloune Y; Stephens EB; Narayan O
Virology; 2009 Jan; 383(1):103-11. PubMed ID: 18986665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
